{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:38:19Z","timestamp":1792697899524,"version":"4.5.0"},"reference-count":32,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2026,9,19]]},"DOI":"10.1080\/10428194.2026.2714343","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:15:30Z","timestamp":1787073330000},"page":"2206-2216","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed\/refractory acute lymphoblastic leukemia"],"prefix":"10.1080","volume":"67","author":[{"given":"Daniel J.","family":"DeAngelo","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana\u2013Farber Cancer Institute","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-2425","authenticated-orcid":false,"given":"Ryan D.","family":"Cassaday","sequence":"additional","affiliation":[{"name":"University of Washington and Fred Hutchinson Cancer Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Hibma","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek Z.","family":"Yang","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Garrett","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetoslav H.","family":"Dimitrov","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New\u00a0York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Vandendries","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1908-3307","authenticated-orcid":false,"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"Leukemia Department, The University of Texas MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00371"},{"key":"e_1_3_4_3_1","unstructured":"Friends of Cancer Research. Optimizing dosing in oncology drug development. 2021; https:\/\/friendsofcancerresearch.org\/wp-content\/uploads\/Optimizing_Dosing_in_Oncology_Drug_Development.pdf. Accessed 24 July 2024."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3298"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13033"},{"key":"e_1_3_4_6_1","unstructured":"US Food and Drug Administration. Optimizing the dosage of human prescription drugs and biological products for the treatment of oncologic diseases guidance for industry. 2023; https:\/\/www.fda.gov\/media\/164555\/download. Accessed 24 July 2024."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2278"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123233"},{"key":"e_1_3_4_9_1","unstructured":"US Food and Drug Administration. Highlights of prescribing information: besponsa. 2017; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761040s003lbl.pdf. Accessed 24 July 2024."},{"key":"e_1_3_4_10_1","unstructured":"European medicines agency. summary of product characteristics: besponsa. 2017; https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/besponsa. Accessed 24 July 2024."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.1900"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.206"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28136"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001925"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509277"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32116"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.04.020"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-018-9614-9"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12841"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903499265"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1500"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286091"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01444-2"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2026.44.16_suppl.e18507"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208875"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27637"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00490"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00546"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35505"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01552-7"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-209438"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-026-01551-6"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00285-X"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2714343","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10428194.2026.2714343","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2714343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:37:56Z","timestamp":1792694276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2026.2714343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,9,19]]}},"alternative-id":["10.1080\/10428194.2026.2714343"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2026.2714343","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}